Sneddon Syndrome (Syndrome, Sneddon)
A systemic non-inflammatory arteriopathy primarily of middle-aged females characterized by the association of livedo reticularis, multiple thrombotic CEREBRAL INFARCTION; CORONARY DISEASE, and HYPERTENSION. Elevation of antiphospholipid antibody titers (see also ANTIPHOSPHOLIPID SYNDROME), cardiac valvulopathy, ISCHEMIC ATTACK, TRANSIENT; SEIZURES; DEMENTIA; and chronic ischemia of the extremities may also occur. Pathologic examination of affected arteries reveals non-inflammatory adventitial fibrosis, thrombosis, and changes in the media. (From Jablonski, Dictionary of Syndromes & Eponymic Diseases, 2d ed; Adams et al., Principles of Neurology, 6th ed, p861; Arch Neurol 1997 Jan;54(1):53-60)
Also Known As:
Syndrome, Sneddon; Sneddon Champion Syndrome; Syndrome, Sneddon-Champion; Livedo Reticularis, Systemic Involvement; Sneddon-Champion Syndrome
Networked: 35
relevant articles (0 outcomes,
1 trials/studies)
Disease Context: Research Results
Related Diseases
Experts
1. | Boëlle, Pierre-Yves:
1 article
(05/2015)
|
2. | Muresan, Ioan-Paul:
1 article
(05/2015)
|
3. | Bottin, Laure:
1 article
(05/2015)
|
4. | de Zuttere, Dominique:
1 article
(05/2015)
|
5. | Alamowitch, Sonia:
1 article
(05/2015)
|
6. | Francès, Camille:
1 article
(05/2015)
|
7. | Giannelou, Angeliki:
1 article
(12/2014)
|
8. | Zhou, Qing:
1 article
(12/2014)
|
9. | Kastner, Daniel L:
1 article
(12/2014)
|
10. | Grigorovici, Mirela:
1 article
(07/2014)
|
Drugs and Biologics
Drugs and Important Biological Agents (IBA) related to Sneddon Syndrome:
Therapies and Procedures